Top compounds associated with response to CLN3


Feature Type Standardized
Nominal ANOVA
mRNA Platin CTRPv2 pan-cancer AAC -0.012 0.8
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.015 0.8
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.013 0.8
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.02 0.8
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.011 0.8
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.01 0.8
Download CSV